Zdrowie i gospodarka · 26/11/2007

FDA Clears ELOXATIN for New Drug Applications

The FDA has determined that ELOXATIN, a 50mg and 100mg per vial oxaliplatin injection, was not withdrawn from sale due to safety or effectiveness concerns, paving the way for approval of abbreviated new drug applications for oxaliplatin sterile lyophilized powder for injection.

Source: Federal Register — Food and Drug AdministrationOpen original release →

Find a company or service

Business Communicator helps companies present their offer, publish updates and connect directly.

Create a company profile Explore businesses on Business Maps →

LATEST SIGNALS

Zdrowie i gospodarka · 10/9/2026

Center for Scientific Review Notice of Closed Meetings

The Center for Scientific Review has announced closed meetings for the following review groups: the Neurological Sciences A Study Section and the Neurological Sciences B Study Section.

Read summary →

Zdrowie i gospodarka · 10/5/2026

CDC Invites Public Comment on Proposed Data Collection for Public Health Crisis Response

The Centers for Disease Control and Prevention (CDC) is seeking public feedback on a proposed data collection project, titled Public Health Crisis Response (PHCR) Cooperative Agreement, which aims to rapidly fund public health programs responding to major emergencies and crises, as required by the Paperwork Reduction Act of 1995.

Read summary →

Zdrowie i gospodarka · 10/5/2026

CDC Requests Public Comment on Respiratory Protective Devices Data Collection

The Centers for Disease Control and Prevention (CDC) is seeking public input on a proposed data collection project related to Respiratory Protective Devices, as required by the Paperwork Reduction Act of 1995, to inform the approval certification activities under 42 CFR part 84.

Read summary →

Zdrowie i gospodarka · 10/5/2026

Federal Agencies Review Forms Under the Paperwork Reduction Act

The Paperwork Reduction Act is being reviewed by federal agencies to streamline and simplify the paperwork process, aiming to reduce bureaucratic burdens on the public.

Read summary →

Zdrowie i gospodarka · 10/5/2026

Center for Scientific Review Amends Meeting Notice

The Center for Scientific Review has updated its meeting notice, making the details publicly available.

Read summary →

Zdrowie i gospodarka · 9/28/2026

CDC Invites Public Comment on Proposed Data Collection for Public Health Emergency Preparedness

The Centers for Disease Control and Prevention (CDC) is seeking public input on a proposed data collection project, titled Public Health Emergency Preparedness (PHEP) Cooperative Agreement, as part of its efforts to reduce public burden and maximize the utility of government information, in accordance with the Paperwork Reduction Act of 1995.

Read summary →